{"id":"W4417498650","doi":"10.1080/21678421.2025.2597935","title":"Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial","year":2025,"lang":"en","type":"article","venue":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Mitsubishi Tanabe Pharma Corporation; Denali Therapeutics; Cytokinetics; Biogen; ALS Association; Muscular Dystrophy Association; Acorda Therapeutics; Arthur M. Blank Family Foundation; UCB Pharma; Alexion Pharmaceuticals","keywords":"Subgroup analysis; Amyotrophic lateral sclerosis; Placebo; Exploratory analysis; Regimen; Clinical endpoint; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007783644,0.001427429,0.004803284,0.0005250676,0.0003903077,0.001237186,0.0007612965,0.001288649,0.002482722],"category_scores_gemma":[0.009184998,0.0004339561,0.008830415,0.0007550102,0.0003908698,0.0007448799,0.000721656,0.001357524,0.0002060573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004223385,"about_ca_system_score_gemma":0.0008881188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001133702,"about_ca_topic_score_gemma":0.003341789,"domain_scores_codex":[0.9946818,0.003425576,0.000722071,0.0005341262,0.0003757277,0.0002606507],"domain_scores_gemma":[0.9957812,0.002286492,0.0008618214,0.0005592773,0.0002627382,0.0002486035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8133538,0.0004061824,0.02693506,0.007450894,0.1153579,0.0003270883,0.0002660455,0.0009518282,0.002671106,0.0002803171,0.002336659,0.02966304],"study_design_scores_gemma":[0.4940318,0.02682163,0.1523784,0.002048343,0.3102757,0.0005391443,0.0005136105,0.002571752,0.001585711,0.002633991,0.006364228,0.0002357797],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8822762,0.1076016,0.001503007,0.0009029752,0.0006932858,0.001614816,0.003407191,0.00006698279,0.001933945],"genre_scores_gemma":[0.986455,0.007959012,0.0007010118,0.0005982401,0.0004360444,0.001328623,0.001849083,0.00003104266,0.0006421093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007783644,"threshold_uncertainty_score":0.04116428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07429008041863687,"score_gpt":0.3323737811230257,"score_spread":0.2580837007043888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}